california dmhc glp-1 coverage exclusion allowed dmhc rules Navigating Changes to Medication GLP-1 insurance change impacts millions

CagriSema, retatrutide, tirzepatide, and amycretin are pushing achievable weight loss into ranges that once required surgery and giving clinicians more than one tool to match to the person in front of them

BMC Endocr Disord

Matrixyl addresses static wrinkles (caused by collagen and elastin loss) through an entirely different mechanism than SNAP-8 (which addresses dynamic wrinkles caused by muscle contraction) or retinoids (which accelerate cell turnover and stimulate collagen through RAR/RXR nuclear receptor activation)

This announcement follows the recent FDA decision that the shortage of this medicine is resolved, with all dose strengths of Wegovy meeting or exceeding both current and projected U.S